Search

Search Results

• TWIST1 Protein Expression in Plasma Cell Neoplasias and Plasmablastic Lymphoma

  Mariya Vladimirovna Melnikova, A.M. Kovrigina, M.V. Soloveva, Yu.A. Chabaeva, S.M. Kulikov, T.N. Obukhova, B.V. Biderman, I.A. Yakutik, A.B. Sudarikov

  70-80

  01.01.2026

• DNA Methylation Genes in Multiple Myeloma: What We Already Know and How It Can Be Used?

  Daria Aleksandrovna Chebykina, E.V. Motyko, A.N. Kirienko, D.V. Kustova, O.B. Krysiuk, S.V. Sidorkevich, I.S. Martynkevich

  315-325

  01.10.2025

• Ibrutinib in Chronic Lymphocytic Leukemia Therapy for High- and Very-High-Risk Patients over 60 Years of Age

  Nadezhda Viktorovna Kurkina, E.A. Repina, E.I. Gorshenina, V.O. Kurkina, P.V. Volkova, A.A. Repin

  37-42

  17.05.2024

• The Prognostic Value of Somatic Mutations of Epigenetic Regulation Genes in Acute Myeloid Leukemias in Real-World Clinical Practice: Results of an Observational Non-Interventional Prospective Interregional Study

  Aleksina Alekseevna Shatilova, I.G. Budaeva, A.V. Petukhov, S.A. Silonov, A.E. Ershova, T.S. Nikulina, Yu.D. Matvienko, Yu.V. Mirolyubova, K.V. Bogdanov, L.V. Anchukova, Yu.S. Neredko, S.Yu. Tyasko, O.E. Ochirova, A.G. Karpova, E.R. Vasil’eva, O.D. Serdyuk, D.A. Yaskulskii, D.V. Bukin, Yu.A. Alekseeva, E.G. Lomaia, L.L. Girshova

  174-185

  03.03.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

  Ekaterina Sergeevna Nesterova, N.A. Severina, B.V. Biderman, A.B. Sudarikov, A.M. Kovrigina, T.N. Obukhova, Ya.K. Mangasarova, S.M. Kulikov, E.E. Zvonkov, E.N. Parovichnikova, V.G. Savchenko

  80-87

  01.01.2023

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Identification of Mutations in IDH1/2, DNMT3A, ASXL1 Genes of Genome Epigenetic Regulation and Their Co-Occurrence with FLT3, NPM1, RUNX1 Mutations in Acute Myeloid Leukemia

  Ekaterina Vasilevna Belotserkovskaya, E.K. Zaikova, A.V. Petukhov, O.N. Demidov, K.A. Levchuk, I.G. Budaeva, D.V. Zaitsev, Yu.D. Rogovaya, A.A. Shatilova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, A.Yu. Zaritskey, L.L. Girshova

  13-21

  01.01.2021

• Molecular Diagnosis of FLT3 Mutations in Acute Myeloid Leukemia Patients

  E.K. Zaikova, Ekaterina Vasil’evna Belotserkovskaya, D.V. Zaytsev, A.V. Petukhov, O.A. Fedorova, D.V. Motorin, V.V. Ivanov, A.Yu. Zaritskey, L.L. Girshova

  150-160

  01.04.2020

• Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

  Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev

  170-175

  01.04.2020

• Current Genetic Models for Prediction of Primary Myelofibrosis

  Lyubov Borisovna Polushkina, V.A. Shuvaev, M.S. Fominykh, Yu.A. Krivolapov, E.A. Belyakova, Z.P. Asaulenko, E.V. Motyko, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, S.V. Voloshin, S.S. Bessmeltsev, A.V. Chechetkin, I.S. Martynkevich

  391-397

  01.10.2019

• WT1 Gene Overexpression in Differential Diagnosis of Ph-negative Myeloproliferative Disorders

  E.G. Lomaia, Nadiya Tamazovna Siordiya, E.G. Lisina, O.M. Senderova, A.A. Silyutina, A.Yu. Zaritskey

  297-302

  01.07.2019

• Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia

  Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, V.V. Strugov, T.O. Andreeva, T.S. Nikulina, Yu.V. Virts, P.A. Butylin, A.G. Rumyantsev, A.Yu. Zaritskey

  167-174

  01.04.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia

  Anastasiya Andreevna Zhernyakova, I.S. Martynkevich, V.A. Shuvaev, L.B. Polushkina, M.S. Fominykh, V.Yu. Udal’eva, I.I. Zotova, D.I. Shikhbabaeva, M.N. Zenina, N.A. Potikhonova, S.V. Voloshin, S.S. Bessmel’tsev, A.V. Chechetkin, K.M. Abdulkadyrov

  402-408

  01.07.2017

• Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey

  141-149

  01.04.2017

• V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia

  Igor’ Vladimirovich Obraztsov, M.A. Gordukova, N.A. Severina, B.V. Biderman, S.Yu. Smirnova, A.B. Sudarikov, E.A. Nikitin, A.G. Rumyantsev

  131-140

  01.04.2017